Atlas Trials

A Randomized Controlled Study of High-dose Cyclophosphamide Induction Therapy in Adult Patients With HLH

Clinical trial NCT05936086 · RECRUITING

Trial details

NCT number
NCT05936086
Sponsor
shifeng Lou
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Hemophagocytic Syndrome
Start date
2023-04-20
Primary completion
2026-04-20
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.